of note is Mark Steinert appearing personally in the Top 20 with close to $1 million of stock.
This guy is the global Head of Equity Research at UBS. Based in NY these days. There are a couple of other UBS relationships in the Top 20 as well - the Goodsall name is one that is well known to many a healthcare investor with Andrew Goodsall the UBS healthcare analyst and #1 ranked in the market. . . .
There are some other solid names on the list too. Will comment further when i have done a little more research.
GBI Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held